Treximet in the Treatment of Chronic Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
Chronic Migraine
Interventions
DRUG

Sumatriptan/Naproxen Sodium

Each tablet of Sumatriptan/Naproxen Sodium for oral administration contains sumatriptan 85mg / naproxen sodium 500mg. Study medication is to be administered 1 tablet per day x 30 days in Treatment Period Month 1. Study medication may be administered on up to 14 days per month in Treatment Period Months 2 and 3.

DRUG

Naproxen Sodium

Each tablet of Naproxen Sodium for oral administration is provided in 500mg tablet. Study medication is to be administered 1 tablet per day x 30 days in Treatment Period Month 1. Study medication may be administered on up to 14 days per month in Treatment Period Months 2 and 3.

Trial Locations (2)

65807

Clinvest, Springfield

78258

Texas Headache Associates, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Cady, Roger, M.D.

INDIV